Answers are grounded in this paper and cite their sources.
Background Diabetic nephropathy (DN) is a major cause of end-stage renal disease, and renal tubular epithelial injury is increasingly recognized as an important contributor to disease progression. However, the molecular mechanisms linking hyperglycemia to sustained inflammatory signaling and tubular damage remain incompletely understood. Methods Transcriptomic analysis was performed on surgically obtained renal cortical tissues from patients with previously biopsy-confirmed DN (n = 11) and diabetic controls without histological evidence of DN (n = 8). Untargeted fecal metabolomic profiling was conducted in separate cohorts of patients with DN (n = 15) and diabetic controls without nephropathy (n = 15). TNFSF9 expression and STAT5 phosphorylation were examined by Western blotting in renal cortical tissues from non-diabetic controls, diabetic controls without nephropathy, and patients with DN (n = 3 per group). Functional experiments were performed in high-glucose-stimulated HK-2 cells using TNFSF9 silencing and overexpression, JAK inhibition, apoptosis assays, wound-healing assays, and Western blotting. The effects of indole-3-propionic acid (IPA) were investigated under defined glucose and TNFSF9-overexpression conditions. Results Transcriptomic screening identified TNFSF9 as an upregulated candidate hub gene in DN, accompanied by enrichment of cytokine-related and JAK–STAT signaling pathways. Human kidney protein analysis confirmed increased TNFSF9 expression and enhanced STAT5 phosphorylation in DN. In HK-2 cells, high glucose increased TNFSF9 expression, promoted apoptosis, impaired wound closure, and enhanced JAK1/STAT5 phosphorylation. TNFSF9 silencing attenuated these changes, whereas overexpression aggravated cellular injury and pathway activation. Tofacitinib reduced JAK1/STAT5 phosphorylation and TNFSF9 protein abundance, suggesting possible reciprocal regulation. Fecal metabolomics revealed altered tryptophan-related metabolism and a modest but significant reduction in IPA abundance in DN. Under combined high-glucose and IPA treatment conditions, TNFSF9 overexpression increased apoptosis and JAK1/STAT5 phosphorylation compared with the matched empty-vector control. Conclusion TNFSF9 contributes to high-glucose-associated tubular epithelial injury and may participate in reciprocal regulation with JAK1/STAT5 signaling. The clinical metabolic findings and cell-based experiments suggest a potential relationship between gut-derived IPA and TNFSF9-associated tubular injury. Further studies are needed to establish the independent protective effects of IPA under high-glucose conditions and clarify the underlying molecular mechanisms.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: